February, 2024
February 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
26272829  
Vivek Subbiah: Meet the amazing Dr. Pamela Kunz, the new Editor of JCO Oncology Advances!
Jan 24, 2024, 16:55

Vivek Subbiah: Meet the amazing Dr. Pamela Kunz, the new Editor of JCO Oncology Advances!

Vivek Subbiah shared a post on X/Twitter:

“Please meet the amazing Dr. Pamela Kunz, the new Editor of ASCO‘s newest journal, JCO Oncology Advances!

It’s a fully open-access, online-only, and interdisciplinary journal. Free for all to read GI24
Learn more about JCO OA.”

Source: Vivek Subbiah/X

Vivek Subbiah is the Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA). He is the former Executive Director of Oncology Research at the MD Anderson Cancer Network and a former Associate Professor in the Department of Investigational Cancer Therapeutics at The University of Texas MD Anderson Cancer Center. Dr. Vivek Subbiah has served as the principal investigator in over 100 phase I/II trials and co-investigator in over 200 clinical trials and is known for his leadership in several first-in-human and practice-changing studies that directly led to approvals from the FDA, European Medicines Agency, and other agencies across the world. He is an expert in tumor agnostic precision oncology and leads the BRAF and RET tissue agnostic studies to FDA approval.